Mirum Pharmaceuticals, Inc. (MIRM)
95.52
+1.93
(+2.06%)
USD |
NASDAQ |
Jun 09, 16:00
95.52
0.00 (0.00%)
After-Hours: 16:59
Mirum Pharmaceuticals SG&A Expense (Quarterly) : 96.33M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 258.30M |
| Incyte Corp. | 328.09M |
| Ionis Pharmaceuticals, Inc. | 150.36M |
| Travere Therapeutics, Inc. | 105.07M |
| Vertex Pharmaceuticals, Inc. | 493.70M |